Literature DB >> 15743800

Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenografts.

Shuqing Liu1, Yufeng Tian, Alexandre Chlenski, Qiwei Yang, Peter Zage, Helen R Salwen, Susan E Crawford, Susan L Cohn.   

Abstract

Neuroblastoma (NB) tumors with abundant schwannian stroma have a differentiated phenotype, low vascularity, and are associated with a favorable prognosis. These observations suggest that cross-talk between Schwann cells and neuroblasts may influence tumor biology. To test this hypothesis, we developed a novel NB xenograft model with infiltrating mouse Schwann cells. Human SMS-KCNR NB cells were injected intrafascicularly (sciatic nerve-engrafted NB, n = 19) or outside the sciatic nerve (control, n = 12). Xenografts were harvested 4 to 12 weeks after tumor cell inoculation for histological studies. Schwann cells were immunostained with S-100 and species-specific p75(NGFR), major histocompatibility complex, and human leukocyte antigen antibodies. The number of proliferating cells, infiltrating Schwann cells, apoptotic cells, differentiated neuroblasts, and blood vessels in the sciatic nerve-engrafted NB tumors were compared to controls. Significantly more Schwann cells were detected in the sciatic nerve-engrafted NB xenografts than controls (P < 0.001). The infiltrating Schwann cells were S-100-positive and reacted with anti-mouse major histocompatibility complex class Ib and p75(NGFR) but not anti-human p75(NGFR) and human leukocyte antigen class I antibodies. The sciatic nerve-engrafted tumors also had lower numbers of proliferating neuroblasts, higher numbers of differentiated neuroblasts and apoptotic cells, and decreased vascular density compared to controls. Our results indicate that infiltrating Schwann cells of mouse origin are capable of promoting human neuroblast differentiation, inducing apoptosis, and inhibiting proliferation and angiogenesis in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15743800      PMCID: PMC1602341          DOI: 10.1016/S0002-9440(10)62309-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell.

Authors:  J Mora; N K Cheung; G Juan; P Illei; I Cheung; M Akram; S Chi; M Ladanyi; C Cordon-Cardo; W L Gerald
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

2.  Therapeutic efficacy of G207 in a novel peripheral nerve sheath tumor model.

Authors:  G A Mashour; H D Moulding; A Chahlavi; G A Khan; S D Rabkin; R L Martuza; P H Driever; A Kurtz; A Chalavi
Journal:  Exp Neurol       Date:  2001-05       Impact factor: 5.330

3.  Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancer.

Authors:  S Liu; S M Edgerton; D H Moore; A D Thor
Journal:  Clin Cancer Res       Date:  2001-06       Impact factor: 12.531

4.  Stromal cells and human malignant neuroblasts derived from bone marrow metastasis may share common karyotypic abnormalities: the case of the IGR-N-91 cell line.

Authors:  A Valent; A M Venuat; G Danglot; J Da Silva; N Duarte; A Bernheim; J Bénard
Journal:  Med Pediatr Oncol       Date:  2001-01

5.  Neuroblastoma cells provoke Schwann cell proliferation in vitro.

Authors:  I M Ambros; A Attarbaschi; S Rumpler; A Luegmayr; E Turkof; H Gadner; P F Ambros
Journal:  Med Pediatr Oncol       Date:  2001-01

6.  Combined M-FISH and CGH analysis allows comprehensive description of genetic alterations in neuroblastoma cell lines.

Authors:  N Van Roy; H Van Limbergen; J Vandesompele; M Van Gele; B Poppe; H Salwen; G Laureys; N Manoel; A De Paepe; F Speleman
Journal:  Genes Chromosomes Cancer       Date:  2001-10       Impact factor: 5.006

7.  Increased TGFbeta type II receptor expression suppresses the malignant phenotype and induces differentiation of human neuroblastoma cells.

Authors:  A Turco; S Scarpa; A Coppa; G Baccheschi; C Palumbo; C Leonetti; G Zupi; G Colletta
Journal:  Exp Cell Res       Date:  2000-02-25       Impact factor: 3.905

8.  Schwann cell-conditioned medium inhibits angiogenesis.

Authors:  D Huang; J L Rutkowski; G M Brodeur; P M Chou; J L Kwiatkowski; A Babbo; S L Cohn
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

9.  SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.

Authors:  Alexandre Chlenski; Shuqing Liu; Susan E Crawford; Olga V Volpert; George H DeVries; Amy Evangelista; Qiwei Yang; Helen R Salwen; Robert Farrer; James Bray; Susan L Cohn
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

10.  Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity.

Authors:  S E Crawford; V Stellmach; M Ranalli; X Huang; L Huang; O Volpert; G H De Vries; L P Abramson; N Bouck
Journal:  J Cell Sci       Date:  2001-12       Impact factor: 5.285

View more
  14 in total

1.  Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma.

Authors:  Kelly R Ostler; Qiwei Yang; Timothy J Looney; Li Zhang; Aparna Vasanthakumar; Yufeng Tian; Masha Kocherginsky; Stacey L Raimondi; Jessica G DeMaio; Helen R Salwen; Song Gu; Alexandre Chlenski; Arlene Naranjo; Amy Gill; Radhika Peddinti; Bruce T Lahn; Susan L Cohn; Lucy A Godley
Journal:  Cancer Res       Date:  2012-07-18       Impact factor: 12.701

2.  Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.

Authors:  Susana Galli; Arlene Naranjo; Collin Van Ryn; Jason U Tilan; Emily Trinh; Chao Yang; Jessica Tsuei; Sung-Hyeok Hong; Hongkun Wang; Ewa Izycka-Swieszewska; Yi-Chien Lee; Olga C Rodriguez; Chris Albanese; Joanna Kitlinska
Journal:  Am J Pathol       Date:  2016-10-12       Impact factor: 4.307

Review 3.  Schwann cells: a new player in the tumor microenvironment.

Authors:  Yuri L Bunimovich; Anton A Keskinov; Galina V Shurin; Michael R Shurin
Journal:  Cancer Immunol Immunother       Date:  2016-11-24       Impact factor: 6.968

4.  Cooperative Cross-Talk between Neuroblastoma Subtypes Confers Resistance to Anaplastic Lymphoma Kinase Inhibition.

Authors:  Xiaocai Yan; Colin R Kennedy; Sarah B Tilkens; Olena Wiedemeier; Hong Guan; Jong-In Park; Andrew M Chan
Journal:  Genes Cancer       Date:  2011-05

5.  Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells.

Authors:  Sandra Acosta; Cinzia Lavarino; Raquel Paris; Idoia Garcia; Carmen de Torres; Eva Rodríguez; Helena Beleta; Jaume Mora
Journal:  BMC Dev Biol       Date:  2009-02-12       Impact factor: 1.978

6.  The neuroblastoma and ganglion components of nodular ganglioneuroblastoma are genetically similar: evidence against separate clonal origins.

Authors:  Paola Angelini; Sylvain Baruchel; Paula Marrano; Meredith S Irwin; Paul S Thorner
Journal:  Mod Pathol       Date:  2014-08-01       Impact factor: 7.842

7.  Reconstitution of Schwannian stroma in neuroblastomas using human bone marrow stromal cells.

Authors:  Wenlin Du; Nobumichi Hozumi; Michiie Sakamoto; Jun-ichi Hata; Taketo Yamada
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

8.  Cell-type-specific transcriptomics in chimeric models using transcriptome-based masks.

Authors:  Felix Naef; Joerg Huelsken
Journal:  Nucleic Acids Res       Date:  2005-07-19       Impact factor: 16.971

9.  Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells.

Authors:  Kristian W Pajtler; Ellen Mahlow; Andrea Odersky; Sven Lindner; Harald Stephan; Ivo Bendix; Angelika Eggert; Alexander Schramm; Johannes H Schulte
Journal:  Oncotarget       Date:  2014-11-30

10.  Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors.

Authors:  Rana Zeine; Helen R Salwen; Radhika Peddinti; Yufeng Tian; Lisa Guerrero; Qiwei Yang; Alexandre Chlenski; Susan L Cohn
Journal:  Mod Pathol       Date:  2009-05-01       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.